Epiphyseal dysplasia multiple
Epiphyseal Dysplasia, Multiple (MED) is a rare genetic disorder affecting the development of the bones. Specifically, it impacts the growth and ossification of the epiphyses, the rounded ends of the long bones, leading to short stature, joint pain, and early-onset osteoarthritis. This condition is part of a group of skeletal disorders known as osteochondrodysplasias.
Causes[edit | edit source]
Multiple Epiphyseal Dysplasia is primarily caused by mutations in several genes, including COMP, COL9A2, COL9A3, and MATN3. These genes are involved in the structural integrity and signaling within the cartilage and bone. MED can be inherited in an autosomal dominant or recessive pattern, depending on the specific gene mutation.
Symptoms[edit | edit source]
The symptoms of Multiple Epiphyseal Dysplasia can vary significantly among individuals but commonly include:
- Mild to moderate short stature
- Joint pain and stiffness
- Limited range of motion in the joints
- Early onset osteoarthritis
- Abnormalities in the hands and feet, such as brachydactyly or clubfoot
Diagnosis[edit | edit source]
Diagnosis of MED involves a combination of clinical evaluation, family history, and imaging studies. X-rays are crucial for visualizing the characteristic epiphyseal abnormalities. Genetic testing can confirm the diagnosis by identifying mutations in the associated genes.
Treatment[edit | edit source]
There is no cure for Multiple Epiphyseal Dysplasia, but treatment focuses on managing symptoms and improving quality of life. Options may include:
- Physical therapy to maintain joint function and mobility
- Pain management strategies, including medications and physical therapy
- Orthopedic interventions, such as surgery, to correct deformities or replace joints damaged by osteoarthritis
Prognosis[edit | edit source]
The prognosis for individuals with Multiple Epiphyseal Dysplasia varies. While the condition does not typically affect life expectancy, it can significantly impact quality of life through chronic pain and mobility issues. Early intervention and management can help mitigate some of these effects.
See Also[edit | edit source]
Epiphyseal dysplasia multiple Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD